PHGE-UN Stock Price, Chart, Stats & News

Headquartered in Ness Ziona, Israel, BiomX Inc. is a clinical-stage biotechnology company established in 2015, dedicated to advancing microbiome-based therapies. The firm harnesses both naturally occurring and genetically engineered bacteriophage technologies to precisely identify and eliminate detrimental bacterial strains. BiomX's therapeutic efforts span conditions impacting skin appearance, as well as a spectrum of chronic diseases, including inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).